Evan Anderson, CEO & Board Member, Luma Therapeutics
Evan Anderson, CEO and Board Member of Luma Therapeutics, has 17 years of experience in early stage product and market development. He completed the Stanford Biodesign Fellowship in 2004 and was first manager of R&D and then distribution sales at Spiracur (acquired by Acelity).
From the Luma Therapeutics website:
We are a medical device company developing light therapies for the 40 million people in the US with inflammatory skin disorders. Luma Therapeutics was born when our CEO Evan Anderson found that he had psoriasis and discovered a way to treat himself effectively. He knew then that he wanted to develop similar treatments for the millions of other people suffering from skin disorders.
We work hard every day to help people get clear skin with easy to use, affordable therapies.
Our goal is to develop an at home treatment that will put psoriasis in remission for an extended period of time after only a few weeks of therapy.
Allyson Schwartz: Tackling “It”
Troy Bannister: Setting the Vision
Lucia Huang: Destigmatizing Mental Health
Dan Trigub: Health Is Moving to the Home
Nicole Walker: From Creating to Capitalizing
Senator Scott Wiener: Your Health, Our Government
Devon Huff: Breaking Barriers
Neal Eigler: Get Traction!
Amrinder Singh: Deliberate and Focused
Andrew Kobylinski: Beyond the Clinic
Josh Miele: A Life of Constant Innovation
Deena Shakir: Driven By a Burning Problem
James Min: The Measure of a Heart
Jon Norris: Are You A Good Investment?
Erika Andersen: The Change Arc
Thomas Tsang: Coming From a Humble Perspective
Jason Lengheier: What’s Your Relationship With Food?
Adrian Fenty: Demand Disruption
Trevor Martin: This Programmable Life
Russell Glass: Solving Staggering Problems
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money